| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41ef34b13b05b0f6b7f08fb2479edadb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C279-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-255 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2015-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2586b492faf26e4cf19a68a67d6840b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6304a3457b40f861a74f271001dce7b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99d539f3f4e601bb04cd80afe4a0171a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb0cc71279892fe2741e19c6df2d4557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9df67be3dfa8dd1a5e4922d9a2b1331d |
| publicationDate |
2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016136136-A1 |
| titleOfInvention |
Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of synapse function |
| abstract |
Compositions and methods for the treatment of Alzheimer's disease and related disorders. More particularly, disclosed are combined therapies that modulate synapse function for treating the disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11717516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10905672-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023034184-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10736876-B2 |
| priorityDate |
2008-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |